Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
The funding will enable development of antibody drugs against ion channels and G-protein-coupled receptors (GPCRs) using proprietary KnotBody® platform, to overcome challenges with this target class for the treatment of Autoimmune diseases and Chronic pain.
Lead Product(s): Antibody
Therapeutic Area: Neurology Product Name: Undisclosed
Highest Development Status: DiscoveryProduct Type: Large molecule
Partner/Sponsor/Collaborator: LifeArc Ventures
Deal Size: $16.0 million Upfront Cash: Undisclosed
Deal Type: Series A Financing February 15, 2023